Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma.

The present study aimed to investigate the association between the methylation status of the reversion-inducing cysteine-rich protein with kazal motifs (RECK) gene and its mRNA expression levels in patients with esophageal squamous cell carcinoma (ESCC). The methylation status of RECK was analyzed by methylation-specific polymerase chain reaction (PCR), and RECK mRNA expression levels were analyzed by quantitative PCR, in 310 paired ESCC tissues. The mean RECK methylation index (MI) was 0.65 in ESCCs and 0.49 in non-tumor samples. There was a significant association between RECK methylation and the American Joint Committee on Cancer stage and lymph node metastasis in ESCC (P<0.0001; P=0.001). The mRNA expression level of RECK was lower in ESCC tissues (mean-∆Cq=-4.66) compared with non-tumor tissues (mean-∆Cq=-2.79), and decreased RECK mRNA expression levels were associated with lymph node metastasis in ESCC. In addition, RECK mRNA levels were decreased in ESCC patients with hypermethylation of the RECK gene (∆MI >0.16; mean-∆∆Cq=-2.85) compared with those with hypomethylation of the RECK gene (∆MI ≤0.16; mean-∆∆Ct=-0.83), and there was a significant difference in the mRNA expression levels of RECK between those with N0-1 and N2-3 lymph node metastasis (P<0.0001). A significant correlation was observed between RECK mRNA expression levels, the MI of RECK and poor postoperative survival (P=0.0003; P<0.0001). The results of the present study suggested that promoter hypermethylation may be an important factor for loss of RECK mRNA expression and may be an indicator of poor survival in ESCC.

[1]  Liu Cao,et al.  DNA Methylation, Its Mediators and Genome Integrity , 2015, International journal of biological sciences.

[2]  T. Beaty,et al.  Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A. , 2014, European journal of cancer.

[3]  E. Andersson,et al.  The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases. , 2014, Anticancer research.

[4]  P. Yin,et al.  Concurrent alterations of RAGE, RECK, and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis, and survival in nasopharyngeal carcinoma. , 2014, International journal of clinical and experimental pathology.

[5]  H. Hiai,et al.  E-cadherin–downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines , 2014, Scientific Reports.

[6]  Wengang Li,et al.  Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis , 2014, Oncology letters.

[7]  Ming-Rong Wang,et al.  Molecular alterations and clinical relevance in esophageal squamous cell carcinoma , 2013, Frontiers of Medicine.

[8]  Donghua Zhang,et al.  Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma , 2013, Oncology letters.

[9]  D. Graham,et al.  Esophageal squamous cell carcinoma with special reference to its early stage. , 2013, Best practice & research. Clinical gastroenterology.

[10]  Yun Chen,et al.  The potential of RECK inducers as antitumor agents for glioma. , 2012, Anticancer research.

[11]  K. Hongo,et al.  Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions , 2012, Journal of Neuro-Oncology.

[12]  Lixin Wei,et al.  The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma , 2012, International journal of biological sciences.

[13]  R. Malekzadeh,et al.  Prognostic Factors for Esophageal Squamous Cell Carcinoma—A Population-Based Study in Golestan Province, Iran, a High Incidence Area , 2011, PloS one.

[14]  Y. M. Lee,et al.  Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways , 2011, Archives of pharmacal research.

[15]  Lixin Wei,et al.  Elevated Expression of the Stem Cell Marker CD133 Associated with Line-1 Demethylation in Hepatocellular Carcinoma , 2011, Annals of Surgical Oncology.

[16]  H. Kitayama,et al.  What we learn from transformation suppressor genes: lessons from RECK. , 2010, Future oncology.

[17]  Y. M. Lee,et al.  Inhibition of Histone Deacetylase Attenuates Hypoxia-Induced Migration and Invasion of Cancer Cells via the Restoration of RECK Expression , 2010, Molecular Cancer Therapeutics.

[18]  Y. M. Lee,et al.  Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. , 2010, Biochimica et biophysica acta.

[19]  D. Dai,et al.  Role of RECK methylation in gastric cancer and its clinical significance. , 2010, World journal of gastroenterology.

[20]  O. Topolcan,et al.  Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC. , 2009, Anticancer research.

[21]  Lixin Wei,et al.  Methylation‐Related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma , 2008, Journal of surgical oncology.

[22]  E. Cho,et al.  CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinoma , 2008, International journal of cancer.

[23]  A. Hara,et al.  Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells , 2008, British Journal of Cancer.

[24]  Kui-Sheng Chen,et al.  Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. , 2007, World journal of gastroenterology.

[25]  David M. Thomas,et al.  RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer , 2007, Cancer and Metastasis Reviews.

[26]  W. Hung,et al.  Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non‐small cell lung cancer , 2006, Cancer science.

[27]  W. Hung,et al.  Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. , 2006, Cancer research.

[28]  Jin Wook Kim,et al.  Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma. , 2006, European journal of cancer.

[29]  G. Sutherland,et al.  Aberrant CBFA2T3B gene promoter methylation in breast tumors , 2004, Molecular Cancer.

[30]  M. Imamura,et al.  RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.